CLINICAL_TRIALS
trial_result
· 2019-06-24
Clinical Trial Update: A Study of LY2605541 and Glargine in Participants With Type 1 Diabetes [Phase 1]
Summary
Phase 1 trial update of LY2605541 and Glargine in participants with Type 1 diabetes has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 1 | Phase 1 | Status: COMPLETED | Results posted: 2019-06-24